All Medicines
Dr. Aditya Singh

Medically Reviewed By

Dr. Aditya Singh, MBBS, MD (Pharmacology)

Reg No: MCI-654321 • Verified Medical Reviewer

Other antineoplastic agents

Kymriah

(tisagenlecleucel)

Uses, side effects, dosage information & price range

Novartis Europharm Limited

About this medicine

Kymriah is indicated for the treatment of: • Paediatric and young adult patients up to and including 25 years of age with B cell acute lymphoblastic leukaemia (ALL) that is refractory, in relapse post transplant or in second or later relapse. • Adult patients with relapsed or refractory diffuse large B cell lymphoma (DLBCL) after two or more lines of systemic therapy. • Adult patients with relapsed or refractory follicular lymphoma (FL) after two or more lines of systemic therapy.

Common Substitutes & Alternatives

These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.

OgsiveoComposition: nirogacestatMerck Europe B.V.
Price on RequestView Details →
Bortezomib HospiraComposition: bortezomibPfizer Europe MA EEIG
Price on RequestView Details →
Topotecan HospiraComposition: topotecanPfizer Europe MA EEIG
Price on RequestView Details →
KrazatiComposition: adagrasibBristol-Myers Squibb Pharma EEIG
Price on RequestView Details →
KinselbyComposition: resminostat4Sc AG
Price on RequestView Details →

Key Information

Salt / Composition

tisagenlecleucel

Category

Other antineoplastic agents

Manufacturer

Novartis Europharm Limited

Need a doctor's consultation?

Don't self-medicate. Consult a doctor before taking any medicine.

Medical Disclaimer

This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.

Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.